Kemper Names Dr. Suzet McKinney of Sterling Bay to Board of Directors, Announces Retirement of Director Christopher Sarofim
February 07 2024 - 2:35PM
Business Wire
Kemper Corporation (NYSE: KMPR) announced that its Board of
Directors has elected Dr. Suzet M. McKinney as a Director,
effective February 7. The Board also announced that Christopher B.
Sarofim has informed the Board of his intention to retire as a
director at the end of his current term, expiring May 1, 2024.
As Principal and Director of Life Sciences for Sterling Bay, the
national real estate investment and development firm, McKinney
oversees relationships with the scientific, academic, corporate,
tech, and governmental sectors involved in the life sciences
ecosystem. She also leads the strategy to expand Sterling Bay’s
footprint in life sciences nationwide. Prior to Sterling Bay, she
held a number of senior leadership roles in public health and
policy administration. McKinney also serves on numerous boards and
advisory committees, including the Board of Directors for Wintrust
Financial Corporation. McKinney holds a Doctorate from the
University of Illinois at Chicago School of Public Health, a Master
of Public Health with certificates in Managed Care and Health Care
Administration from Benedictine University, and a Bachelor of Arts
in Biology from Brandeis University.
“We’re pleased to welcome Suzet to our board,” said Joseph P.
Lacher, Jr., President, CEO and Chairman of Kemper’s Board of
Directors. “Her leadership of large organizations, business
experience, strategic execution, and deep familiarity with the
Chicago business community make her an excellent addition to
Kemper’s board, and we look forward to the benefits of her
perspective and contributions.”
“It’s an exciting time for Kemper as they move forward and I’m
pleased to join the board to help advance the strategic priorities
of the company,” said McKinney. “I believe in Kemper’s commitment
to serve the underserved and look forward to working with my fellow
board members and the talented senior leadership team in support of
that mission.”
Sarofim was elected to Kemper’s Board in May 2013, and has
served on the Board’s Investment Committee. He currently serves as
Chairman of Fayez, Sarofim & Co., a leader in the financial
services and investment management industry. His community and
charitable commitments include serving on the Board of Trustees for
The Brown Foundation and Baylor College of Medicine, a member of
the Advisory Committee for MD Anderson Cancer Center, and as the
Chairman of the Board of Trustees of the Sarofim Foundation.
“Kemper has been very fortunate to have Chris’s leadership on
our Board for nearly 11 years, and we thank him for his dedicated
service and outstanding contributions,” said Lacher. “His
investment management expertise has been of great value to the
Board, and his financial market and investment banking experience
has been beneficial to the Board. He’s been a highly effective
director, and we extend our gratitude and best wishes to Chris and
his family.”
“It’s been an honor serving on Kemper’s board over the last 11
years, and I couldn’t be prouder of what we’ve accomplished,”
Sarofim said. “I leave with the utmost confidence in both the
leadership team and the company’s prospects for the future, and
know the outstanding Board and management will continue to
successfully execute on Kemper’s strategic intent.”
About Kemper
The Kemper family of companies is one of the nation's leading
specialized insurers. With approximately $13 billion in assets,
Kemper is improving the world of insurance by providing affordable
and easy-to-use personalized solutions to individuals, families and
businesses through its Kemper Auto and Kemper Life brands. Kemper
serves over 4.9 million policies, is represented by 23,700 agents
and brokers, and has 8,100 associates dedicated to meeting the
ever-changing needs of its customers. Learn more about
Kemper.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240207702896/en/
News Media: Barbara Ciesemier, 312.661.4521,
bciesemier@kemper.com Investors: Karen Guerra, 312.661.4930,
investors@kemper.com
Kemper (NYSE:KMPR)
Historical Stock Chart
From Apr 2024 to May 2024
Kemper (NYSE:KMPR)
Historical Stock Chart
From May 2023 to May 2024